학술논문
Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial
Document Type
Article
Author
Source
In: Leukemia Research . (Leukemia Research, January 2020, 88)
Subject
Language
English
ISSN
18735835
01452126
01452126